Choosing The Best Needle Free Connector in 2017 · 2017-12-12 · Choosing The Best Needle Free Connector in 2017 11TH PICC Day ‘The Complications’ GAVeCeLT December 2017 ...

1

ChoosingTheBestNeedleFreeConnector

in2017

11THPICCDay‘TheComplications’

GAVeCeLT

December2017

NancyTrickRN,CRNI

Disclosure •  Employee

ManagerWWClinicalMarketingEvidence&EducationInfusionDisposablesBectonDickinsonVernonHills,IL

2

Nooff-labeluseofproductwillbediscussedduringthispresentation

3

Objectives •  Considerthecriteriaofa‘bestneedlefreeconnector’

•  Discusstheimpactofneedlefreeconnectordesignondocumentedriskofcontamination&complications

•  DescribeaUSA-based,FDAmandatetoaddressthethreatofBSIsspecifictoneedlefreeconnectordesign

•  Outlineresolution&product-specificimplicationsastheresultoftheFDAmandate

INS SOP #34 The Primary Purpose Needleless Connectors

4

‘To protect health care personnel by eliminating needles and subsequent needlestick injuries when attaching

administration sets and/or syringes to the VAD hub or injection site for intermittent infusion’

5

Needle Free Connectors What is ‘Best’?

LeastAmountPatientRisk

ReliablePerformance

SustainablePerformance

RepeatablePerformance

Substantial3rdPartyClinicalEvidence

ReduceNeedleStickInjuriestoHCP

BSI Occlusion

7

Evolution “unfolding,change,progression,metamorphosis.”Dictionary.com

TheEvolutionofLight....

Allprovideasourceoflight

•  Allhavevaryingdegreeofriskassociatedwithuse

Designsevolvedtoimprove:Safety~Effectiveness~Efficiencies

Evolution of Needle Free Technology: USA

1980’s 1991 2000 2001 2005 2008

Bloodbornepathogenexposurerisksgaingreaterattention

OccupationalSafety&HealthAdministration(OSHA)recommendshealthcarefacilitiesuse“engineeringcontrols”tohelpprotectHealthCareWorkersfromthesepathogens

NeedlestickSafetyandPreventionAct(Pub.L106-430)signedintolaw

Engineeredcontrols,includingNeedlelessConnector(NC)systemsmandatoryunderNeedlestickSafetyandPreventionAct

FDArecognizesmicrobialriskwithNC’sTestingshoulddemonstratedisinfectionproceduresusedareeffectiveforremovingmicroorganismsfromthedevice

FDArevisesGuidanceTestingshoulddemonstratedisinfectionproceduresareeffective

HealthcareWorkerProtection PatientProtection

8

Generations of Needle Free Technology

9

•  Allprovideanaccesspoint

Allhavevaryingdegreesofriskandbenefitsassociatedwithprotocolsforuseinvariousclinicalsettings

TermsNegative/PositivePressureMechanicalValves

wereintroduced

TermNeutralwas

introduced

TermAnti-Reflux

Introduced

Designsevolvedtoimprove:Safety~Effectiveness~Efficiencies

NFC Design & Fluid Dynamics

10

Negative Displacement NC. Allows blood reflux into vascular access device (VAD) lumen upon disconnection due to movement of valve mechanism or removal of syringe/set Positive Displacement NC. Allows a small amount of fluid to be held in the device; upon set or syringe disconnection, this fluid is pushed through the catheter lumen to clear any blood that refluxed into the lumen Neutral NC. Contains an internal mechanism designed to prevent blood reflux into the catheter lumen upon connection or disconnection Anti-Reflux NC. Contains a pressure-sensitive internal mechanism designed to prevent blood reflux into the catheter lumen when the flow of infusion solution has stopped

Clinical Practice Highly Influences Effective Flushing & Locking Technique

11

NFC Features that Increase Risk Infection Difficultycleaningaccesssurface

HCW’smaynotadequatelycleantheintricatesurfacedetails,leadingtofluidpathcontamination.

Gaparoundplungerharborsbacteria

GapcannotbeaccessedfordisinfectionandcanleadtofluidpathcontaminationespeciallywithrepeatedaccesssuchasSASorSASHmethod.

Opaquehousinghidesincompleteflushingofmediabasedfluids

Duringthecourseofnormalmanipulationofthecathetersmallamountsofmedialikefluidcontaminatethevalve.Iftheseorganismsproliferate,thentheycanbeinfusedwithsubsequentmanipulations.

Internalmechanismsobscurefluidpath

Impossibletovisuallyconfirmcompleteflushing.

1.WilliamJarvis,MD–PresentedatCHICA(CommunityandHospitalInfectionControlAssociation)February24,2009,APICandAVA2006,SHEA2005,2006.

12

•  FDA concerned about the safety of positive pressure needle free connectors after receiving three reports of death associated with bloodstream infections and positive displacement needleless connectors

•  The FDA cited multiple clinical reports showing an association between multi-branded, positive displacement needless connectors and bloodstream infections and a subsequent reduction in bloodstream infections when facilities switched to another type of needleless connector

2010FDAPostMarketingSurveillanceMandate

13

2010 FDA 522 Mandate 9 Manufacturers Post-marketing surveillance required 1)Whatistherateofbloodstreaminfectionsforsubjectsreceivingyourpositivedisplacementconnectorforcentrallineaccessandisitstatisticallynon-inferiortotheratesseeninsubjectsreceivingotherneedlelessconnectors(e.g.negative,neutral,orsplit-septumconnectors)forcentrallineaccess,givencomparablepatientpopulations?2)Aretherepatientdemographics,comorbidities/severityofillness,ordevicecleaningpracticesforwhichplacementofyourpositivedisplacementconnectorforcentrallineaccessincreasessubjects’riskofbloodstreaminfectionscomparedwithotherneedlelessconnectors?

14

15

16

16

CaseReportsNarrative/Expertopinion/Nodesign

CaseControlStudiesRetrospective/Lookingforriskfactors

Animal&LaboratoryStudiesNohumans

CohortStudiesProspective/Measuringexposedrisk

RCTProspective/testingRx

Meta-AnalysisSystematicReviews

ClinicalPracticeGuidelinesStrengthofE

vide

nce

AvailabilityofStrongEvidenceBasedonabilitytocontrolforbiasandtodemonstratecause&effectinhumans

PyramidofEvidence

17

In-Vitro Study Completed

StudyPurpose:Identifyanydifferencesbetweentheratesofmicrobialingressintodifferentdevicesfollowingcontamination.

•  Tested5secondand15seconddisinfectionprotocols•  7-dayclinicalsimulation=repeatedmicrobialcontaminationofaccesssurfaceanddisinfectionfollowedbysalineflushes

•  Plusbloodaspirationthroughthedevices,mimickingblooddiscardandsampling,commonlycarriedoutinclinicalpractice

AnnaCasey,PhD,BSc,TarjaKarpanen,PhD,BSc,RGN’PeterNightingale,PhD,BSc,TomElliott,PhD,DSc,MRCP,BM,BS,BMedSci,FRCPath“AnInVitroComparisonofMicrobialIngressInto8DifferentNeedlelessIVAccessDevices”JournalofInfusionNursing,Volume38,Number1,January/February2015

JournalofInfusionNursingJanuary2015(AnnaCaseyetal)

18

Interesting Conclusions •  TheMaxPluswasassociatedwithingressofsignificantly

fewermicroorganismscomparedwiththeotherdevicestested

•  SignificantlyfewerCFUwererecoveredfromneedlelessIVaccessdeviceswithrelativelylargeprimingvolumes,suchasMaxPlus,thanthosewithsmallprimingvolumes

•  TheMaxPluswasassociatedwithsignificantlyfewercontaminatedadministrationsetmaleluersthantheotherdevicestested,whichsupportstheconjecturethattheinjectionsitedesignmayprotectthemaleluersterility

19

20

AnalysisofstudiesreportingCLABSIsinpatientswhenusingapositivedisplacementneedlefreeconnector(studyNFC)comparedwith

negativeorneutraldisplacementneedlefreeconnectors

21

Meta-Analysis Literature

22

23

24

25

Thisarticlehasbeenretracted:pleaseseeElsevierPolicyonArticleWithdrawal(http://www.elsevier.com/locate/withdrawalpolicy).ThisarticlehasbeenretractedattherequestoftheEditor-in-Chief.AninvestigationintoanallegedfailuretodiscloseCOIwasconductedbyaninterdisciplinaryscientificreviewcommitteeconvenedbyseniorleadershipatGeorgiaRegentsUniversity(GRU).Thecommitteereachedthefindingsofafailuretoproperlydisclosetherelationship.Duringthecourseofthatinvestigation,questionswereraisedaboutthemethodsanddatapresentedinthisarticle.Thequestionsfocusedinparticularontheconsistencyofthestatisticsovervariousstudyperiodsaswellasthemethodsbywhichstudysiteswerechosen.Theinvestigationconcludedthatthesciencewasflawed

26

27

“USAHospitalCompareAnalysis”

27

The advantages of using publicly reported outcome data such as used in this study include:

•  There was no sampling bias, because all eligible hospitals were included

•  There was no potential conflict of interest compared to data collected by manufacturers themselves

•  It was the most current with minimal time lag •  The comparison was concurrent, which eliminated potential bias

inherent to pre-post period study designs

In order to satisfy an FDA post-market surveillance request (known as a ‘522’), CareFusion undertook the largest analysis known to-date for needleless connectors. Used 2013 Center for Medicare and Medicaid Services Hospital Compare data •  3,074 hospitals •  Nearly 11,000 recorded events •  Nearly 10 million catheter days •  Merged with Manufacturer’s client database

29

‘Hospital Compare Results’

30

Source: Tabak et al Poster 897 IDWEEK 2014

* Hospitals with > 1 CLD

31

MaxPlus is a registered trademark of CareFusion Corporation or one of its subsidiaries. All other trademarks are the property of their respective owners.

32

33

FDA Post Market Surveillance

This is the future for medical devices

34

35 © 2015-001 CareFusion Corporation or one of its subsidiaries. All rights reserved.

Final Thoughts Preferred Design & Extended Usage

36

Featurestoimprovedisinfecting&flushingtechniques:

•  Solidaccesssurface•  Sealedbetweenaccesssurfaceandhousing

•  Completelyfluidfilleddesignwithaonepieceinternalmechanism

(nointernalcannulaorcomplicateddesign)

JarvisWR.NeedlelessConnectorsandimprovementofPatientandHealthcareProfessionalSafety.InfectionControlToday.December2013

37

MyPride&Joy!!

[email protected]

'Canadá(7YO)&EmeryMarie(2YO)